SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001161697-23-000647
Filing Date
2023-12-29
Accepted
2023-12-29 17:00:22
Documents
1
Period of Report
2023-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 FOR 12-27-2023 form_4.html 4  
1 FORM 4 FOR 12-27-2023 form_4.xml 4 5836
  Complete submission text file 0001161697-23-000647.txt   7542
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address
Harper Molly (Reporting) CIK: 0001871470 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33057 | Film No.: 231528398